| Mrs Kristie Kay Gamble, CRNA | |
|
900 Hospital Dr, Madisonville, KY 42431-1644 | |
| (270) 825-5100 | |
| Not Available |
| Full Name | Mrs Kristie Kay Gamble |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 900 Hospital Dr, Madisonville, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407822729 | NPI | - | NPPES |
| 000000201261 | Other | KY | ANTHEM BCBS- BAPTIST HEALTH |
| 74402942 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 3001377 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kristie Kay Gamble, CRNA 200 Clinic Dr, Madisonville, KY 42431-1661 Ph: () - | Mrs Kristie Kay Gamble, CRNA 900 Hospital Dr, Madisonville, KY 42431-1644 Ph: (270) 825-5100 |
News Archive
City of Hope researchers received approval from the U.S. Food and Drug Administration (FDA) to conduct the first-in-human study of a neural stem cell-based therapy targeting recurrent high-grade gliomas, the most aggressive type of brain tumor. Karen S. Aboody, M.D., associate professor in City of Hope's Department of Neurosciences, leads the research team that developed this treatment strategy. Jana Portnow, M.D., assistant professor and assistant director of the Brain Tumor Program at City of Hope, is the principal investigator for the clinical trial.
Having your doctor ask you about your family breast health history can greatly increase the chances of identifying your risk for breast cancer.
Scientific research published in the current issue of the Journal of the American Medical Informatics Association (JAMIA) reports on a study of genetic variants that influence human susceptibility to peripheral arterial disease (PAD), made possible by leveraging electronic medical records (EMRs; also called EHRs or electronic health records).
Abbott, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of a pivotal Phase 3 clinical trial designed to evaluate the safety and efficacy of elagolix in female patients with endometriosis.
› Verified 5 days ago
Michael David Crider, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 900 Hospital Dr, Madisonville, KY 42431 Phone: 270-825-5100 | |
Tammy Ann Bishop, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7346 | |
Travis Laffoon, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 900 Hospital Dr, Madisonville, KY 42431 Phone: 270-824-3682 Fax: 270-824-3675 | |
Ronald Ray Wilson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 900 Hospital Dr, Madisonville, KY 42431 Phone: 270-825-5100 | |
Rihana Paige Mcknight, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 900 Hospital Dr, Madisonville, KY 42431 Phone: 270-350-3703 | |
Michelle A. Addington, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 | |
John W. Sciarini, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 |